Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

DOACs associated with reduced risk of major bleeding compared to warfarin

DOACs associated with reduced risk of major bleeding compared to warfarin

July 11 2018 Direct oral anticoagulants (DOACs) have been associated with reduced risks of major...

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

July 3 2018 People who have a record of penicillin allergy are at an increased risk of developing...

MPS advises of need for better awareness of cauda equina red flag symptoms

MPS advises of need for better awareness of cauda equina red flag symptoms

May 9 2018 The Medical Protection Society is advising doctors of a revision to the NICE Clinical...

Anticholinergics linked to increased risk of dementia

Anticholinergics linked to increased risk of dementia

April 30 2018 Anticholinergic drugs used in helping control some involuntary muscle movement...

  • Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Thursday, 19 July 2018 10:36
  • DOACs associated with reduced risk of major bleeding compared to warfarin

    DOACs associated with reduced risk of major bleeding compared to warfarin

    Wednesday, 11 July 2018 13:22
  • Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Tuesday, 03 July 2018 16:51
  • MPS advises of need for better awareness of cauda equina red flag symptoms

    MPS advises of need for better awareness of cauda equina red flag symptoms

    Wednesday, 09 May 2018 16:01
  • Anticholinergics linked to increased risk of dementia

    Anticholinergics linked to increased risk of dementia

    Monday, 30 April 2018 12:20

welsh government logo cb 1August 1 2017
The Welsh Government has renewed its commitment to supporting people with neurological conditions by setting out its plans for 2017-2020.

 

 

 

 

 

Among the priorities highlighted in this latest plan are:

  • Raising awareness of neurological conditions by involving patients and carers in designing services
  • Ensuring timely diagnosis of neurological conditions by calling on Health Boards to provide specialist advice within 24 hours (on seven day week basis) for those admitted acutely to hospital with a suspected neurological problem
  • Making sure those living with a neurological condition have access to care and support as close to home as possible by a flexible workforce with the appropriate level of evidence based knowledge, skill and expertise.

Its new Neurological Conditions Delivery Plan updates the initial three year plan introduced in 2014. Among the progress made on original plan priorities in the three years to 2017 has been a reduction in the time patients with neurological conditions have needed to spend in secondary care:

  • the average time an individual spends in hospital fell from 6.4 days in 2010-11 to 4.2 days in 2015-16
  • the length of stay following an elective admission has reduced from 3.9 days to 2.2 days;
  • stays following emergency admissions fell from an average of 9.2 days to 7 days.

Health Secretary Vaughan Gething said: “We have already committed to investing £1.2m to improve access to neuro-rehabilitation services in Wales. The neurological conditions implementation group prioritises raising awareness of conditions, including the development of patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) to consistently improve the service.

“We want health boards to use this funding to make tangible differences in the health, wellbeing and independence of people living with long-term neurological conditions.”

Link:
Welsh Government announcement  

Clinical News

July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...